Visualitza VHIO - Articles científics per autor "INSA, AMELIA"
Ara mostrant els elements 1-3 d 3
-
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
Serna-Blasco, Roberto; Garcia‑Campelo, Rosario; Casal Rubio, Joaquín; Martínez Marti, Alexandre; Insa, Amelia; Provencio, Mariano; Nadal, Ernest (American Society of Clinical Oncology, 2022-09-01) -
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy
Casarrubios García, Marta; Cruz-Bermúdez, Alberto; Martínez Marti, Alexandre; Martínez Marti, Alexandre; Insa, Amelia; Nadal, Ernest; Lázaro, Martín; Garcia Campelo, Rosario (American Association for Cancer Research, 2021-11-01) -
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy
Casarrubios García, Marta; Garcia‑Campelo, Rosario; Martínez Marti, Alexandre; Insa, Amelia; Provencio, Mariano; Nadal, Ernest; Lázaro, Martín (BMJ, 2022-09)